156 related articles for article (PubMed ID: 38141079)
1. Endovascular closure of a congenital extrahepatic portosystemic shunt for the treatment of hepatopulmonary syndrome in an infant.
Bhatte S; Cahill AM; Dunn M; Foran A; Perez A; Acord MR
Pediatr Radiol; 2024 Feb; 54(2):357-361. PubMed ID: 38141079
[TBL] [Abstract][Full Text] [Related]
2. Congenital extrahepatic portosystemic shunt: an underdiagnosed but treatable cause of hepatopulmonary syndrome.
Fu L; Wang Q; Wu J; Guo Y; Huang M; Liu T; Chen Q; Li F
Eur J Pediatr; 2016 Feb; 175(2):195-201. PubMed ID: 26311567
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disorders in patients with congenital portosystemic shunts: 23 years of experience in a tertiary referral centre.
Lambert V; Ladarre D; Fortas F; Durand P; Hervé P; Gonzales E; Guérin F; Savale L; McLin VA; Ackermann O; Franchi-Abella S;
Arch Cardiovasc Dis; 2021 Mar; 114(3):221-231. PubMed ID: 33281106
[TBL] [Abstract][Full Text] [Related]
4. Portal venous remodeling after endovascular reduction of pediatric autogenous portosystemic shunts.
Stewart JK; Kuo WT; Hovsepian DM; Hofmann LV; Bonham CA; Sze DY
J Vasc Interv Radiol; 2011 Aug; 22(8):1199-205. PubMed ID: 21801995
[TBL] [Abstract][Full Text] [Related]
5. Hepatopulmonary Syndrome in an Adolescent With Insidious Hypoxia and Small Intrahepatic Portal Venous Shunts: Posttransplant Benefit From Sildenafil.
Slowik V; Hildreth A; Pacheco MC; Finn LS; King J; Shivaram G; Files M; Hsu EK; Horslen S
Pediatr Dev Pathol; 2020; 23(6):467-471. PubMed ID: 32813578
[TBL] [Abstract][Full Text] [Related]
6. Neurological Symptoms of Congenital Portosystemic Shunt Reversed by Venous Endovascular Intervention: A Six Years Follow-Up Study.
Riolo FM; Alvarez DP; Villegas MO; Díaz JA
Neurol India; 2020; 68(4):930-933. PubMed ID: 32859847
[TBL] [Abstract][Full Text] [Related]
7. Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease.
Boike JR; Flamm SL
Clin Liver Dis; 2020 Aug; 24(3):373-388. PubMed ID: 32620278
[TBL] [Abstract][Full Text] [Related]
8. Endovascular treatment of a portosystemic shunt presenting with hypoglycemia; case presentation and review of literature.
Ghasemi-Rad M; Smuclovisky E; Cleveland H; Hernandez JA
Clin Imaging; 2022 Mar; 83():131-137. PubMed ID: 35033850
[TBL] [Abstract][Full Text] [Related]
9. Hepatic encephalopathy due to a congenital portosystemic shunt: a disease with a changeable presentation.
Alventosa Mateu C; Urquijo Ponce JJ; Diago Madrid M
Rev Esp Enferm Dig; 2020 Jun; 112(6):508-509. PubMed ID: 32496112
[TBL] [Abstract][Full Text] [Related]
10. Congenital portosystemic shunts: diagnosis and treatment.
Franchi-Abella S; Gonzales E; Ackermann O; Branchereau S; Pariente D; Guérin F;
Abdom Radiol (NY); 2018 Aug; 43(8):2023-2036. PubMed ID: 29730740
[TBL] [Abstract][Full Text] [Related]
11. Exploiting phenotypic plasticity for the treatment of hepatopulmonary shunting in Abernethy malformation.
Kuo MD; Miller FJ; Lavine JE; Peterson M; Finch M
J Vasc Interv Radiol; 2010 Jun; 21(6):917-22. PubMed ID: 20399112
[TBL] [Abstract][Full Text] [Related]
12. Complications of congenital portosystemic shunts: liver tumors are affected by shunt severity, but pulmonary and neurocognitive associations are not.
Tyraskis A; Davenport M; Deganello A; Sellars M; De Vito C; Kane P; Thompson RJ; Quaglia A; Heaton N
Hepatol Int; 2022 Aug; 16(4):918-925. PubMed ID: 35802226
[TBL] [Abstract][Full Text] [Related]
13. Abernethy Malformations: Evaluation and Management of Congenital Portosystemic Shunts.
Rajeswaran S; Johnston A; Green J; Riaz A; Thornburg B; Mouli S; Lautz T; Lemoine C; Superina R; Donaldson J
J Vasc Interv Radiol; 2020 May; 31(5):788-794. PubMed ID: 32107126
[TBL] [Abstract][Full Text] [Related]
14. Congenital portosystemic shunts in children: recognition, evaluation, and management.
Bernard O; Franchi-Abella S; Branchereau S; Pariente D; Gauthier F; Jacquemin E
Semin Liver Dis; 2012 Nov; 32(4):273-87. PubMed ID: 23397528
[TBL] [Abstract][Full Text] [Related]
15. Characterization and natural history of congenital intrahepatic portosystemic shunts.
Cytter-Kuint R; Slae M; Kvyat K; Shteyer E
Eur J Pediatr; 2021 Jun; 180(6):1733-1737. PubMed ID: 33481107
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Surgical Ligation versus Endovascular Embolization for Type II Congenital Extrahepatic Portosystemic Shunt.
Zhang J; Duan W; Fang Z; Wang M; Cui L; Bai Y; Li X; Du Q; Shen M; Duan F
Biomed Res Int; 2021; 2021():9951393. PubMed ID: 34159206
[TBL] [Abstract][Full Text] [Related]
17. Hepatopulmonary syndrome successfully treated with transjugular intrahepatic portosystemic shunt: a three-year follow-up.
Chevallier P; Novelli L; Motamedi JP; Hastier P; Brunner P; Bruneton JN
J Vasc Interv Radiol; 2004 Jun; 15(6):647-8. PubMed ID: 15178729
[No Abstract] [Full Text] [Related]
18. Congenital absence of portal vein presenting as hepatopulmonary syndrome.
Cheung KM; Lee CY; Wong CT; Chan AK
J Paediatr Child Health; 2005; 41(1-2):72-5. PubMed ID: 15670231
[TBL] [Abstract][Full Text] [Related]
19. Catheter interventional treatment of congenital portosystemic venous shunts in childhood.
Knirsch W; Benz DC; Bühr P; Quandt D; Weber R; Kellenberger C; Braegger CP; Kretschmar O
Catheter Cardiovasc Interv; 2016 Jun; 87(7):1281-92. PubMed ID: 26715199
[TBL] [Abstract][Full Text] [Related]
20. Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shunt.
Nistal MW; Pace A; Klose H; Benten D; Lohse AW
Thorax; 2013 Sep; 68(9):889-90. PubMed ID: 22382598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
